» Articles » PMID: 33581000

Power Formulas for Mixed Effects Models with Random Slope and Intercept Comparing Rate of Change Across Groups

Overview
Journal Int J Biostat
Specialty Public Health
Date 2021 Feb 13
PMID 33581000
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously derived power calculation formulas for cohort studies and clinical trials using the longitudinal mixed effects model with random slopes and intercepts to compare rate of change across groups [Ard & Edland, Power calculations for clinical trials in Alzheimer's disease. J Alzheim Dis 2011;21:369-77]. We here generalize these power formulas to accommodate 1) missing data due to study subject attrition common to longitudinal studies, 2) unequal sample size across groups, and 3) unequal variance parameters across groups. We demonstrate how these formulas can be used to power a future study even when the design of available pilot study data (i.e., number and interval between longitudinal observations) does not match the design of the planned future study. We demonstrate how differences in variance parameters across groups, typically overlooked in power calculations, can have a dramatic effect on statistical power. This is especially relevant to clinical trials, where changes over time in the treatment arm reflect background variability in progression observed in the placebo control arm plus variability in response to treatment, meaning that power calculations based only on the placebo arm covariance structure may be anticonservative. These more general power formulas are a useful resource for understanding the relative influence of these multiple factors on the efficiency of cohort studies and clinical trials, and for designing future trials under the random slopes and intercepts model.

Citing Articles

A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease.

Brum W, De Bastiani M, Bieger A, Therriault J, Ferrari-Souza J, Benedet A Alzheimers Dement (N Y). 2022; 8(1):e12270.

PMID: 35310530 PMC: 8918110. DOI: 10.1002/trc2.12270.


Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.

Smirnov D, Salmon D, Galasko D, Goodwill V, Hansen L, Zhao Y Neurology. 2021; 98(5):e506-e517.

PMID: 34810247 PMC: 8826459. DOI: 10.1212/WNL.0000000000013107.

References
1.
Tu X, Zhang J, Kowalski J, Shults J, Feng C, Sun W . Power analyses for longitudinal study designs with missing data. Stat Med. 2006; 26(15):2958-81. DOI: 10.1002/sim.2773. View

2.
Browne R . On the use of a pilot sample for sample size determination. Stat Med. 1995; 14(17):1933-40. DOI: 10.1002/sim.4780141709. View

3.
Jung S, Ahn C . Sample size estimation for GEE method for comparing slopes in repeated measurements data. Stat Med. 2003; 22(8):1305-15. DOI: 10.1002/sim.1384. View

4.
Wang C, Hall C, Kim M . A comparison of power analysis methods for evaluating effects of a predictor on slopes in longitudinal designs with missing data. Stat Methods Med Res. 2012; 24(6):1009-29. PMC: 3913747. DOI: 10.1177/0962280212437452. View

5.
Edland S, Ard M, Li W, Jiang L . Design of pilot studies to inform the construction of composite outcome measures. Alzheimers Dement (N Y). 2017; 3(2):213-218. PMC: 5596916. DOI: 10.1016/j.trci.2016.12.004. View